Mitochondrial Function Differences between Tumor Tissue of Human Metastatic and Premetastatic CRC

Area of Science:

• Mitochondrial biology
• Cancer research
• Metabolic pathways

Background:

• Colorectal cancer (CRC) metastasis is a primary cause of patient mortality.
• Mitochondrial dysfunction is implicated in cancer development and metastatic spread.
• Understanding mitochondrial adaptations in CRC is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate mitochondrial function adaptations in stages III and IV CRC tumor tissues.
• To determine if these adaptations can serve as therapeutic targets for metastatic CRC (mCRC).

Main Methods:

• Analysis of protein levels via Western blotting.
• Measurement of enzymatic activities of mitochondrial proteins.
• Quantification of mitochondrial DNA (mtDNA) using real-time PCR.
• Comparison of tumor tissues with adjacent non-tumor tissues from CRC patients.

Main Results:

• Pre-metastatic stage III CRC tumor tissues showed an oxidant metabolic profile similar to non-tumor tissues.
• Metastatic stage IV CRC tumor tissues exhibited significant differences in protein expression (ATPase, IDH2, LDHA, SIRT1) and mtDNA levels compared to non-tumor tissues.
• Evidence of impaired mitochondrial function in stage IV CRC tumor tissue.

Conclusions:

• A shift in oxidative metabolic profile occurs in tumor tissue upon reaching the metastatic stage.
• Tumor tissue oxidative metabolism contributes to the promotion and maintenance of the metastatic phenotype in CRC.
• Mitochondrial function impairment in stage IV CRC highlights its role in metastasis.